Basal Bolus

DRUG4 trials

Sponsors

Guillermo Umpierrez, MD, Emory University, University of Campania Luigi Vanvitelli

Conditions

HyperglycemiaType 2 Diabetes

Phase 4

Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)

CompletedNCT00979628

Guillermo Umpierrez, MDHyperglycemia, Type 2 Diabetes

Start: 2010-01-31End: 2012-06-30Updated: 2018-10-10

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

CompletedNCT01845831

Emory UniversityType 2 Diabetes

Start: 2013-08-31End: 2016-04-30Updated: 2017-05-30

Linagliptin Inpatient Trial

CompletedNCT02004366

Emory UniversityType 2 Diabetes

Start: 2014-01-31End: 2017-03-31Updated: 2019-02-20

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

CompletedNCT04196231

University of Campania Luigi VanvitelliType 2 Diabetes

Start: 2019-11-27End: 2020-10-20Updated: 2020-10-22

Related Papers

BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes

Endocrine2023-10-038 citations

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.

2016-12-08111 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01